Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Assessment of Membrane Fluidity Fluctuations during Cellular Development Reveals Time and Cell Type Specificity.

Noutsi P, Gratton E, Chaieb S.

PLoS One. 2016 Jun 30;11(6):e0158313. doi: 10.1371/journal.pone.0158313. eCollection 2016.

2.

Neuraminidase-1 contributes significantly to the degradation of neuronal B-series gangliosides but not to the bypass of the catabolic block in Tay-Sachs mouse models.

Timur ZK, Akyildiz Demir S, Marsching C, Sandhoff R, Seyrantepe V.

Mol Genet Metab Rep. 2015 Aug 15;4:72-82. doi: 10.1016/j.ymgmr.2015.07.004. eCollection 2015 Sep.

3.

Quantitative GSL-glycome analysis of human whole serum based on an EGCase digestion and glycoblotting method.

Furukawa J, Sakai S, Yokota I, Okada K, Hanamatsu H, Kobayashi T, Yoshida Y, Higashino K, Tamura T, Igarashi Y, Shinohara Y.

J Lipid Res. 2015 Dec;56(12):2399-407. doi: 10.1194/jlr.D062083. Epub 2015 Sep 28.

4.

Systems toxicology approaches enable mechanistic comparison of spontaneous and cigarette smoke-related lung tumor development in the A/J mouse model.

Luettich K, Xiang Y, Iskandar A, Sewer A, Martin F, Talikka M, Vanscheeuwijck P, Berges A, Veljkovic E, Gonzalez-Suarez I, Schlage W, Hoeng J, Peitsch M.

Interdiscip Toxicol. 2014 Jun;7(2):73-84. doi: 10.2478/intox-2014-0010. Epub 2014 Nov 15.

5.

Ganglioside biochemistry.

Kolter T.

ISRN Biochem. 2012 Dec 19;2012:506160. doi: 10.5402/2012/506160. eCollection 2012. Review.

6.

Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.

Barnes S, Xu YH, Zhang W, Liou B, Setchell KD, Bao L, Grabowski GA, Sun Y.

PLoS One. 2014 Dec 31;9(12):e116023. doi: 10.1371/journal.pone.0116023. eCollection 2014.

7.

Neurologic abnormalities in mouse models of the lysosomal storage disorders mucolipidosis II and mucolipidosis III γ.

Idol RA, Wozniak DF, Fujiwara H, Yuede CM, Ory DS, Kornfeld S, Vogel P.

PLoS One. 2014 Oct 14;9(10):e109768. doi: 10.1371/journal.pone.0109768. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e114199.

8.

Variation in 12 porcine genes involved in the carbohydrate moiety assembly of glycosphingolipids does not account for differential binding of F4 Escherichia coli and their fimbriae.

Goetstouwers T, Van Poucke M, Coddens A, Nguyen VU, Melkebeek V, Deforce D, Cox E, Peelman LJ.

BMC Genet. 2014 Oct 3;15:103. doi: 10.1186/s12863-014-0103-x.

9.

Decreased amyloid-β pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice.

Yuyama K, Sun H, Sakai S, Mitsutake S, Okada M, Tahara H, Furukawa J, Fujitani N, Shinohara Y, Igarashi Y.

J Biol Chem. 2014 Aug 29;289(35):24488-98. doi: 10.1074/jbc.M114.577213. Epub 2014 Jul 18.

10.

Lipidomics of glycosphingolipids.

Farwanah H, Kolter T.

Metabolites. 2012 Feb 2;2(1):134-64. doi: 10.3390/metabo2010134.

11.

Lysosomal storage diseases and the heat shock response: convergences and therapeutic opportunities.

Ingemann L, Kirkegaard T.

J Lipid Res. 2014 Nov;55(11):2198-210. doi: 10.1194/jlr.R048090. Epub 2014 May 16. Review.

12.

Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration.

Schnaar RL, Gerardy-Schahn R, Hildebrandt H.

Physiol Rev. 2014 Apr;94(2):461-518. doi: 10.1152/physrev.00033.2013. Review.

13.

Inhibition of GM3 synthase attenuates neuropathology of Niemann-Pick disease Type C. by affecting sphingolipid metabolism.

Lee H, Lee JK, Bae YC, Yang SH, Okino N, Schuchman EH, Yamashita T, Bae JS, Jin HK.

Mol Cells. 2014 Feb;37(2):161-71. doi: 10.14348/molcells.2014.2347. Epub 2014 Feb 19.

14.

Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia.

Boukhris A, Schule R, Loureiro JL, Lourenço CM, Mundwiller E, Gonzalez MA, Charles P, Gauthier J, Rekik I, Acosta Lebrigio RF, Gaussen M, Speziani F, Ferbert A, Feki I, Caballero-Oteyza A, Dionne-Laporte A, Amri M, Noreau A, Forlani S, Cruz VT, Mochel F, Coutinho P, Dion P, Mhiri C, Schols L, Pouget J, Darios F, Rouleau GA, Marques W Jr, Brice A, Durr A, Zuchner S, Stevanin G.

Am J Hum Genet. 2013 Jul 11;93(1):118-23. doi: 10.1016/j.ajhg.2013.05.006. Epub 2013 Jun 6.

15.

Manipulating ionic strength to improve single cell electrophoretic separations.

Keithley RB, Metzinger MP, Rosado AM, Dovichi NJ.

Talanta. 2013 Jul 15;111:206-14. doi: 10.1016/j.talanta.2013.03.012. Epub 2013 Mar 13.

16.

Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease.

Potter GB, Santos M, Davisson MT, Rowitch DH, Marks DL, Bongarzone ER, Petryniak MA.

Hum Mol Genet. 2013 Sep 1;22(17):3397-414. doi: 10.1093/hmg/ddt190. Epub 2013 Apr 24.

17.

Gangliosides and ceramides change in a mouse model of blast induced traumatic brain injury.

Woods AS, Colsch B, Jackson SN, Post J, Baldwin K, Roux A, Hoffer B, Cox BM, Hoffer M, Rubovitch V, Pick CG, Schultz JA, Balaban C.

ACS Chem Neurosci. 2013 Apr 17;4(4):594-600. doi: 10.1021/cn300216h. Epub 2013 Jan 17.

18.

Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice.

Sun Y, Zamzow M, Ran H, Zhang W, Quinn B, Barnes S, Witte DP, Setchell KD, Williams MT, Vorhees CV, Grabowski GA.

Hum Mol Genet. 2013 Jun 15;22(12):2435-50. doi: 10.1093/hmg/ddt096. Epub 2013 Feb 27.

19.

Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.

Fragaki K, Ait-El-Mkadem S, Chaussenot A, Gire C, Mengual R, Bonesso L, Bénéteau M, Ricci JE, Desquiret-Dumas V, Procaccio V, Rötig A, Paquis-Flucklinger V.

Eur J Hum Genet. 2013 May;21(5):528-34. doi: 10.1038/ejhg.2012.202. Epub 2012 Sep 19.

20.

Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection.

Puryear WB, Gummuluru S.

Adv Exp Med Biol. 2013;762:131-53. doi: 10.1007/978-1-4614-4433-6_5. Review.

Supplemental Content

Support Center